State‐of‐the‐art therapies for Rett syndrome
Nicolas Panayotis(Centre National de la Recherche Scientifique), Jean‐Christophe Roux(Inserm), Marie‐Solenne Félix(Inserm), Yann Ehinger(Inserm)
Cited by 41
Related Papers
Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome
|Neurobiology of Disease|2020|58
A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome
|Neurobiology of Disease|2016|46